Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Venture Life ( (GB:VLG) ) has provided an announcement.
Venture Life Group PLC, a leader in the global consumer healthcare sector, has announced the posting of a notice for a general meeting to shareholders, along with the release of their Annual Report for the year ending December 2024. The general meeting is scheduled for 5 August 2025 in London, following their annual general meeting held on 30 June 2025. Additionally, the company will hold an investor presentation on 3 July 2025, led by CEO Jerry Randall and CFO Daniel Wells, to discuss the final results for the year ended December 2024. This presentation is open to all existing and potential shareholders, allowing them to submit questions in advance or during the live event.
More about Venture Life
Venture Life is an international consumer self-care company based in the UK, specializing in the commercialization of products for the global self-care market. Their product portfolio includes Balance Activ for women’s intimate healthcare, Earol for ENT care, Lift and Glucogel for energy and glucose management, and the Health and Her range for hormonal lifecycle support. These products are primarily distributed through health & beauty stores, pharmacies, grocery multiples, and e-commerce channels, with direct supply to retailers in the UK, Ireland, and the USA, and through international distribution partners elsewhere.
Average Trading Volume: 351,461
Technical Sentiment Signal: Buy
Current Market Cap: £64.35M
See more insights into VLG stock on TipRanks’ Stock Analysis page.